All News
Filter News
Found 808,679 articles
-
Andromeda Biotech Successfully Completes Patient Recruitment in Phase III Confirmatory Trial for Its Lead Drug, "DiaPep277" for Type 1 Diabetes
9/12/2012
-
Oncolytics Biotech Inc. Provides Update on Phase III Study of REOLYSIN® in Head and Neck Cancers
9/12/2012
-
Transcept Pharmaceuticals, Inc. Completes Patient Enrollment in Phase 2 Clinical Trial of TO-2061 Added as Adjunctive Therapy for Obsessive Compulsive Disorder
9/12/2012
-
Bionor Pharma ASA Release: Analysis of Immune Responses in Patients Treated With Vacc-4x Supports Further Development
9/12/2012
-
TetraPhase Pharmaceuticals Announces Positive Phase 2 Data for Eravacycline (TP-434) in Patients With Complicated Intra-Abdominal Infections (cIAIs)
9/12/2012
-
Opexa Therapeutics Initiates Late Stage Clinical Study of Tcelna in Patients With Secondary Progressive Multiple Sclerosis (SPMS)
9/12/2012
-
European Medicines Agency Grants Orphan Designation to Edison Pharmaceuticals, Inc. for EPI-743 for Treatment of Leigh Syndrome
9/12/2012
-
KaloBios Pharmaceuticals, Inc. Initiates Phase 2 Study With KB003 Humaneered™ Monoclonal Antibody in Severe Asthma
9/12/2012
-
e-Therapeutics plc Starts Second Phase I Cancer Trial of ETS2101
9/12/2012
-
Cambridge Based Biotech, Phico Therapeutics, Announces Milestone in the Fight Against Multidrug Resistant Bacteria Enzyme NDM-1
9/12/2012
-
PRANA Biotechnology Receives Recommendation to Proceed With Alzheimer's Clinical Trial From Data Safety Monitoring Board (DSMB)
9/12/2012
-
Rib-X Pharmaceuticals, Inc. Presents Data from Multiple Radezolid Studies at ICAAC Including Successful Intravenous Dosing in Phase 1 and Favorable Long-Term Safety and Tolerability Vs. Linezolid in Vivo
9/12/2012
-
Synergy Pharmaceuticals Files IND for SP-333, a Developmental Drug for Gastrointestinal Diseases
9/12/2012
-
Published Preclinical Data Demonstrate Ability of Gliknik Inc.'s Recombinant Stradomers™ to Mimic Anti-Autoimmune Effect of IVIG
9/12/2012
-
Sapheon, Inc. Announces Completed Enrollment in VenaSeal™ eSCOPE Study
9/12/2012
-
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Advances Type 1 Diabetes Stem Cell Technology Licensed From Yale University School Of Medicine
9/12/2012
-
Rib-X Pharmaceuticals, Inc. Reports Preclinical Studies at ICAAC With Novel Classes of RX-04 Antibiotic Compounds Demonstrating Potent and Rapid Efficacy in a S. pneumoniae Lung Model of Infection and Activity Against a Diverse Spectrum of Biodefense Path
9/12/2012
-
Plasma Surgical Release: First Long-Term Study Evaluating the Use of Plasma Energy to Treat Endometrioma
9/12/2012
-
Boehringer Ingelheim GmbH Release: Asian Populations With Atrial Fibrillation (AF) Benefit From Better Stroke Prevention With Pradaxa® (dabigatran etexilate) Compared to Warfarin
9/12/2012
-
Aethlon Medical Discloses MD Anderson Presentation
9/12/2012